Table of Content

1 Sustained and Controlled Release Formulations Market Overview
1.1 Sustained and Controlled Release Formulations Product Overview
1.2 Sustained and Controlled Release Formulations Market Segment by Type
1.2.1 Generic Drug
1.2.2 Original Drug
1.3 Global Sustained and Controlled Release Formulations Market Size by Type
1.3.1 Global Sustained and Controlled Release Formulations Market Size Overview by Type (2018-2029)
1.3.2 Global Sustained and Controlled Release Formulations Historic Market Size Review by Type (2018-2024)
1.3.3 Global Sustained and Controlled Release Formulations Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
1.4.2 Europe Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
2 Global Sustained and Controlled Release Formulations Market Competition by Company
2.1 Global Top Players by Sustained and Controlled Release Formulations Sales (2018-2024)
2.2 Global Top Players by Sustained and Controlled Release Formulations Revenue (2018-2024)
2.3 Global Top Players by Sustained and Controlled Release Formulations Price (2018-2024)
2.4 Global Top Manufacturers Sustained and Controlled Release Formulations Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sustained and Controlled Release Formulations Market Competitive Situation and Trends
2.5.1 Sustained and Controlled Release Formulations Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Sustained and Controlled Release Formulations Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained and Controlled Release Formulations as of 2022)
2.7 Date of Key Manufacturers Enter into Sustained and Controlled Release Formulations Market
2.8 Key Manufacturers Sustained and Controlled Release Formulations Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sustained and Controlled Release Formulations Status and Outlook by Region
3.1 Global Sustained and Controlled Release Formulations Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sustained and Controlled Release Formulations Historic Market Size by Region
3.2.1 Global Sustained and Controlled Release Formulations Sales in Volume by Region (2018-2024)
3.2.2 Global Sustained and Controlled Release Formulations Sales in Value by Region (2018-2024)
3.2.3 Global Sustained and Controlled Release Formulations Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Sustained and Controlled Release Formulations Forecasted Market Size by Region
3.3.1 Global Sustained and Controlled Release Formulations Sales in Volume by Region (2024-2029)
3.3.2 Global Sustained and Controlled Release Formulations Sales in Value by Region (2024-2029)
3.3.3 Global Sustained and Controlled Release Formulations Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sustained and Controlled Release Formulations by Application
4.1 Sustained and Controlled Release Formulations Market Segment by Application
4.1.1 Cardiovascular System Drugs
4.1.2 Nervous System Drugs
4.1.3 Digestive System and Metabolism
4.1.4 Other
4.2 Global Sustained and Controlled Release Formulations Market Size by Application
4.2.1 Global Sustained and Controlled Release Formulations Market Size Overview by Application (2018-2029)
4.2.2 Global Sustained and Controlled Release Formulations Historic Market Size Review by Application (2018-2024)
4.2.3 Global Sustained and Controlled Release Formulations Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
4.3.2 Europe Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
5 North America Sustained and Controlled Release Formulations by Country
5.1 North America Sustained and Controlled Release Formulations Historic Market Size by Country
5.1.1 North America Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sustained and Controlled Release Formulations Sales in Volume by Country (2018-2024)
5.1.3 North America Sustained and Controlled Release Formulations Sales in Value by Country (2018-2024)
5.2 North America Sustained and Controlled Release Formulations Forecasted Market Size by Country
5.2.1 North America Sustained and Controlled Release Formulations Sales in Volume by Country (2024-2029)
5.2.2 North America Sustained and Controlled Release Formulations Sales in Value by Country (2024-2029)
6 Europe Sustained and Controlled Release Formulations by Country
6.1 Europe Sustained and Controlled Release Formulations Historic Market Size by Country
6.1.1 Europe Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sustained and Controlled Release Formulations Sales in Volume by Country (2018-2024)
6.1.3 Europe Sustained and Controlled Release Formulations Sales in Value by Country (2018-2024)
6.2 Europe Sustained and Controlled Release Formulations Forecasted Market Size by Country
6.2.1 Europe Sustained and Controlled Release Formulations Sales in Volume by Country (2024-2029)
6.2.2 Europe Sustained and Controlled Release Formulations Sales in Value by Country (2024-2029)
7 Asia-Pacific Sustained and Controlled Release Formulations by Region
7.1 Asia-Pacific Sustained and Controlled Release Formulations Historic Market Size by Region
7.1.1 Asia-Pacific Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sustained and Controlled Release Formulations Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Sustained and Controlled Release Formulations Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Sustained and Controlled Release Formulations Forecasted Market Size by Region
7.2.1 Asia-Pacific Sustained and Controlled Release Formulations Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sustained and Controlled Release Formulations Sales in Value by Region (2024-2029)
8 Latin America Sustained and Controlled Release Formulations by Country
8.1 Latin America Sustained and Controlled Release Formulations Historic Market Size by Country
8.1.1 Latin America Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sustained and Controlled Release Formulations Sales in Volume by Country (2018-2024)
8.1.3 Latin America Sustained and Controlled Release Formulations Sales in Value by Country (2018-2024)
8.2 Latin America Sustained and Controlled Release Formulations Forecasted Market Size by Country
8.2.1 Latin America Sustained and Controlled Release Formulations Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sustained and Controlled Release Formulations Sales in Value by Country (2024-2029)
9 Middle East and Africa Sustained and Controlled Release Formulations by Country
9.1 Middle East and Africa Sustained and Controlled Release Formulations Historic Market Size by Country
9.1.1 Middle East and Africa Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sustained and Controlled Release Formulations Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Sustained and Controlled Release Formulations Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Sustained and Controlled Release Formulations Forecasted Market Size by Country
9.2.1 Middle East and Africa Sustained and Controlled Release Formulations Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sustained and Controlled Release Formulations Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Humanwell Healthcare Co.,Ltd.
10.1.1 Humanwell Healthcare Co.,Ltd. Company Information
10.1.2 Humanwell Healthcare Co.,Ltd. Introduction and Business Overview
10.1.3 Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Products Offered
10.1.5 Humanwell Healthcare Co.,Ltd. Recent Development
10.2 Nanjing Yiheng Pharmaceutical Co., Ltd.
10.2.1 Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
10.2.2 Nanjing Yiheng Pharmaceutical Co., Ltd. Introduction and Business Overview
10.2.3 Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Products Offered
10.2.5 Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Development
10.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
10.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
10.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Introduction and Business Overview
10.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Products Offered
10.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Development
10.4 Qilu Pharmaceutical Co Ltd
10.4.1 Qilu Pharmaceutical Co Ltd Company Information
10.4.2 Qilu Pharmaceutical Co Ltd Introduction and Business Overview
10.4.3 Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Products Offered
10.4.5 Qilu Pharmaceutical Co Ltd Recent Development
10.5 Shanghai Pharmaceuticals Holding Co.,Ltd.
10.5.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
10.5.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Introduction and Business Overview
10.5.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Products Offered
10.5.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Development
10.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
10.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
10.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Introduction and Business Overview
10.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Products Offered
10.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Development
10.7 PKU HealthCare Corp.,Ltd.
10.7.1 PKU HealthCare Corp.,Ltd. Company Information
10.7.2 PKU HealthCare Corp.,Ltd. Introduction and Business Overview
10.7.3 PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.7.4 PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Products Offered
10.7.5 PKU HealthCare Corp.,Ltd. Recent Development
10.8 Overseas Pharmaceuticals, Ltd.
10.8.1 Overseas Pharmaceuticals, Ltd. Company Information
10.8.2 Overseas Pharmaceuticals, Ltd. Introduction and Business Overview
10.8.3 Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Products Offered
10.8.5 Overseas Pharmaceuticals, Ltd. Recent Development
10.9 Novast Laboratories (China), LTD.
10.9.1 Novast Laboratories (China), LTD. Company Information
10.9.2 Novast Laboratories (China), LTD. Introduction and Business Overview
10.9.3 Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Products Offered
10.9.5 Novast Laboratories (China), LTD. Recent Development
10.10 Catalent
10.10.1 Catalent Company Information
10.10.2 Catalent Introduction and Business Overview
10.10.3 Catalent Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Catalent Sustained and Controlled Release Formulations Products Offered
10.10.5 Catalent Recent Development
10.11 AstraZeneca Plc
10.11.1 AstraZeneca Plc Company Information
10.11.2 AstraZeneca Plc Introduction and Business Overview
10.11.3 AstraZeneca Plc Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.11.4 AstraZeneca Plc Sustained and Controlled Release Formulations Products Offered
10.11.5 AstraZeneca Plc Recent Development
10.12 Oakwood Labs
10.12.1 Oakwood Labs Company Information
10.12.2 Oakwood Labs Introduction and Business Overview
10.12.3 Oakwood Labs Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Oakwood Labs Sustained and Controlled Release Formulations Products Offered
10.12.5 Oakwood Labs Recent Development
10.13 Ascendia Pharma
10.13.1 Ascendia Pharma Company Information
10.13.2 Ascendia Pharma Introduction and Business Overview
10.13.3 Ascendia Pharma Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Ascendia Pharma Sustained and Controlled Release Formulations Products Offered
10.13.5 Ascendia Pharma Recent Development
10.14 Colorcon
10.14.1 Colorcon Company Information
10.14.2 Colorcon Introduction and Business Overview
10.14.3 Colorcon Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Colorcon Sustained and Controlled Release Formulations Products Offered
10.14.5 Colorcon Recent Development
10.15 Pfizer Inc.
10.15.1 Pfizer Inc. Company Information
10.15.2 Pfizer Inc. Introduction and Business Overview
10.15.3 Pfizer Inc. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Pfizer Inc. Sustained and Controlled Release Formulations Products Offered
10.15.5 Pfizer Inc. Recent Development
10.16 Mylan
10.16.1 Mylan Company Information
10.16.2 Mylan Introduction and Business Overview
10.16.3 Mylan Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Mylan Sustained and Controlled Release Formulations Products Offered
10.16.5 Mylan Recent Development
10.17 Sandoz
10.17.1 Sandoz Company Information
10.17.2 Sandoz Introduction and Business Overview
10.17.3 Sandoz Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Sandoz Sustained and Controlled Release Formulations Products Offered
10.17.5 Sandoz Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sustained and Controlled Release Formulations Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sustained and Controlled Release Formulations Industrial Chain Analysis
11.4 Sustained and Controlled Release Formulations Market Dynamics
11.4.1 Sustained and Controlled Release Formulations Industry Trends
11.4.2 Sustained and Controlled Release Formulations Market Drivers
11.4.3 Sustained and Controlled Release Formulations Market Challenges
11.4.4 Sustained and Controlled Release Formulations Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sustained and Controlled Release Formulations Distributors
12.3 Sustained and Controlled Release Formulations Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Generic Drug
Table 2. Major Company of Original Drug
Table 3. Global Sustained and Controlled Release Formulations Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 5. Global Sustained and Controlled Release Formulations Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US& Million)
Table 7. Global Sustained and Controlled Release Formulations Market Share in Value by Type (2018-2024)
Table 8. Global Sustained and Controlled Release Formulations Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (K Units)
Table 10. Global Sustained and Controlled Release Formulations Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Sustained and Controlled Release Formulations Sales Market Share in Value by Type (2024-2029)
Table 13. Global Sustained and Controlled Release Formulations Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 15. North America Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 17. Europe Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 21. Latin America Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Sustained and Controlled Release Formulations Sales by Company (2018-2024) & (K Units)
Table 25. Global Sustained and Controlled Release Formulations Sales Share by Company (2018-2024)
Table 26. Global Sustained and Controlled Release Formulations Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Sustained and Controlled Release Formulations Revenue Share by Company (2018-2024)
Table 28. Global Market Sustained and Controlled Release Formulations Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Sustained and Controlled Release Formulations Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Sustained and Controlled Release Formulations Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained and Controlled Release Formulations as of 2022)
Table 32. Date of Key Manufacturers Enter into Sustained and Controlled Release Formulations Market
Table 33. Key Manufacturers Sustained and Controlled Release Formulations Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Sustained and Controlled Release Formulations Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 37. Global Sustained and Controlled Release Formulations Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Sustained and Controlled Release Formulations Sales Market Share in Value by Region (2018-2024)
Table 40. Global Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 42. Global Sustained and Controlled Release Formulations Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Sustained and Controlled Release Formulations Sales Market Share in Value by Region (2024-2029)
Table 45. Global Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Sustained and Controlled Release Formulations Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (K Units)
Table 48. Global Sustained and Controlled Release Formulations Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Sustained and Controlled Release Formulations Sales Market Share in Value by Application (2018-2024)
Table 51. Global Sustained and Controlled Release Formulations Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (K Units)
Table 53. Global Sustained and Controlled Release Formulations Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Sustained and Controlled Release Formulations Sales Market Share in Value by Application (2024-2029)
Table 56. Global Sustained and Controlled Release Formulations Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 58. North America Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 60. Europe Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 64. Latin America Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 68. North America Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2018-2024)
Table 71. North America Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 72. North America Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 76. Europe Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 80. Europe Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Sustained and Controlled Release Formulations Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Sustained and Controlled Release Formulations Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Sustained and Controlled Release Formulations Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Sustained and Controlled Release Formulations Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2024-2029)
Table 107. Humanwell Healthcare Co.,Ltd. Company Information
Table 108. Humanwell Healthcare Co.,Ltd. Introduction and Business Overview
Table 109. Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Product
Table 111. Humanwell Healthcare Co.,Ltd. Recent Development
Table 112. Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
Table 113. Nanjing Yiheng Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 114. Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Product
Table 116. Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Development
Table 117. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
Table 118. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Introduction and Business Overview
Table 119. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Product
Table 121. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Development
Table 122. Qilu Pharmaceutical Co Ltd Company Information
Table 123. Qilu Pharmaceutical Co Ltd Introduction and Business Overview
Table 124. Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Product
Table 126. Qilu Pharmaceutical Co Ltd Recent Development
Table 127. Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
Table 128. Shanghai Pharmaceuticals Holding Co.,Ltd. Introduction and Business Overview
Table 129. Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Product
Table 131. Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Development
Table 132. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 133. Yangtze River Pharmaceutical (Group) Co., Ltd. Introduction and Business Overview
Table 134. Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Product
Table 136. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Development
Table 137. PKU HealthCare Corp.,Ltd. Company Information
Table 138. PKU HealthCare Corp.,Ltd. Introduction and Business Overview
Table 139. PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Product
Table 141. PKU HealthCare Corp.,Ltd. Recent Development
Table 142. Overseas Pharmaceuticals, Ltd. Company Information
Table 143. Overseas Pharmaceuticals, Ltd. Introduction and Business Overview
Table 144. Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Product
Table 146. Overseas Pharmaceuticals, Ltd. Recent Development
Table 147. Novast Laboratories (China), LTD. Company Information
Table 148. Novast Laboratories (China), LTD. Introduction and Business Overview
Table 149. Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Product
Table 151. Novast Laboratories (China), LTD. Recent Development
Table 152. Catalent Company Information
Table 153. Catalent Introduction and Business Overview
Table 154. Catalent Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Catalent Sustained and Controlled Release Formulations Product
Table 156. Catalent Recent Development
Table 157. AstraZeneca Plc Company Information
Table 158. AstraZeneca Plc Introduction and Business Overview
Table 159. AstraZeneca Plc Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. AstraZeneca Plc Sustained and Controlled Release Formulations Product
Table 161. AstraZeneca Plc Recent Development
Table 162. Oakwood Labs Company Information
Table 163. Oakwood Labs Introduction and Business Overview
Table 164. Oakwood Labs Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Oakwood Labs Sustained and Controlled Release Formulations Product
Table 166. Oakwood Labs Recent Development
Table 167. Ascendia Pharma Company Information
Table 168. Ascendia Pharma Introduction and Business Overview
Table 169. Ascendia Pharma Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Ascendia Pharma Sustained and Controlled Release Formulations Product
Table 171. Ascendia Pharma Recent Development
Table 172. Colorcon Company Information
Table 173. Colorcon Introduction and Business Overview
Table 174. Colorcon Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Colorcon Sustained and Controlled Release Formulations Product
Table 176. Colorcon Recent Development
Table 177. Pfizer Inc. Company Information
Table 178. Pfizer Inc. Introduction and Business Overview
Table 179. Pfizer Inc. Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Pfizer Inc. Sustained and Controlled Release Formulations Product
Table 181. Pfizer Inc. Recent Development
Table 182. Mylan Company Information
Table 183. Mylan Introduction and Business Overview
Table 184. Mylan Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Mylan Sustained and Controlled Release Formulations Product
Table 186. Mylan Recent Development
Table 187. Sandoz Company Information
Table 188. Sandoz Introduction and Business Overview
Table 189. Sandoz Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Sandoz Sustained and Controlled Release Formulations Product
Table 191. Sandoz Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Sustained and Controlled Release Formulations Market Trends
Table 195. Sustained and Controlled Release Formulations Market Drivers
Table 196. Sustained and Controlled Release Formulations Market Challenges
Table 197. Sustained and Controlled Release Formulations Market Restraints
Table 198. Sustained and Controlled Release Formulations Distributors List
Table 199. Sustained and Controlled Release Formulations Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Sustained and Controlled Release Formulations Product Picture
Figure 2. Global Sustained and Controlled Release Formulations Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Sustained and Controlled Release Formulations Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Sustained and Controlled Release Formulations Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Generic Drug
Figure 6. Global Generic Drug Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Original Drug
Figure 8. Global Original Drug Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Sustained and Controlled Release Formulations Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Sustained and Controlled Release Formulations Sales Market Share by Type in 2022 & 2029
Figure 11. North America Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 12. North America Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 13. Europe Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 14. Europe Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 17. Latin America Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Sustained and Controlled Release Formulations Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Sustained and Controlled Release Formulations Revenue in 2022
Figure 23. Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Cardiovascular System Drugs
Figure 25. Global Cardiovascular System Drugs Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Nervous System Drugs
Figure 27. Global Nervous System Drugs Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Digestive System and Metabolism
Figure 29. Global Digestive System and Metabolism Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Sustained and Controlled Release Formulations Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Sustained and Controlled Release Formulations Sales Market Share by Application in 2022 & 2029
Figure 34. North America Sustained and Controlled Release Formulations Sales Market Share in Volume by Application in 2022
Figure 35. North America Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 36. Europe Sustained and Controlled Release Formulations Sales Market Share in Volume by Application in 2022
Figure 37. Europe Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Sustained and Controlled Release Formulations Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 40. Latin America Sustained and Controlled Release Formulations Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Sustained and Controlled Release Formulations Manufacturing Cost Structure
Figure 45. Sustained and Controlled Release Formulations Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed